Mid-Term Outcomes of TAVR in Intermediate-Risk Patients: Potential Targets for Improvement. Verma S, Bhatt DL, Tang GHL. J Am Coll Cardiol 2023;82:124-127.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Verma S, Bhatt DL, Tang GHL. Mid-Term Outcomes of TAVR in Intermediate-Risk Patients: Potential Targets for Improvement. J Am Coll Cardiol 2023;82:124-127.
PMID: 37407111